Novartis Aktie
127,80
EUR
+0,55
EUR
+0,43
%
117,48
CHF
+1,36
CHF
+1,17
%
Werbung
Novartis Aktie Analyse
| 22.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 08.04.22 | Novartis Neutral | UBS AG | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 14.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Neutral | UBS AG | |
| 09.02.22 | Novartis Equal-weight | Morgan Stanley | |
| 03.02.22 | Novartis Neutral | UBS AG | |
| 03.02.22 | Novartis Sell | Deutsche Bank AG | |
| 03.02.22 | Novartis Neutral | Credit Suisse Group | |
| 02.02.22 | Novartis Market-Perform | Bernstein Research | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | Barclays Capital | |
| 25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 14.01.22 | Novartis Equal-weight | Morgan Stanley | |
| 12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.01.22 | Novartis Neutral | UBS AG | |
| 04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.12.21 | Novartis Sell | Deutsche Bank AG | |
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.12.21 | Novartis Neutral | Credit Suisse Group | |
| 07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 06.12.21 | Novartis Sell | Deutsche Bank AG | |
| 03.12.21 | Novartis Neutral | UBS AG | |
| 03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novartis Neutral | UBS AG | |
| 11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
| 05.11.21 | Novartis Neutral | UBS AG | |
| 04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung